John Furey
CIK 1691218 · Chief Operating Officer · last filed 2025-06-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$144.3K
Companies
4
Total Filings
14
Lifetime Open-Market Net
-$3.20M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PCVX | Director | 3,041 | $47.46 | $144.3K | $0 | 2 | 2025-06-16 |
| Adaptimmune Therapeutics PLC (ADAP) Delisted | Director | — | $0.06 | — | $0 | 5 | 2024-07-01 |
| ASND | Director | — | $218.06 | — | $0 | 1 | 2019-07-03 |
| Spark Therapeutics, Inc. (ONCE) Delisted | Chief Operating Officer | 18 | — | — | -$3.20M | 6 | 2018-04-24 |
Recent Filings · Page 2 of 2
14 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-04-16 | Spark Therapeutics, Inc. (ONCE) Delisted | Mixed | — | -$555.4K | EDGAR |
| 2018-01-22 | Spark Therapeutics, Inc. (ONCE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-01-22 | Spark Therapeutics, Inc. (ONCE) Delisted | Mixed | — | $489 | EDGAR |
| 2016-12-05 | Spark Therapeutics, Inc. (ONCE) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–14 of 14
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.